100 related articles for article (PubMed ID: 2195624)
21. [The TEAM study--a study of the effectiveness and tolerance of treatment of essential hypertension with a fixed combination of trandolapril and verapamil].
Widimský J; Dzúrik R
Vnitr Lek; 1998 Jun; 44(6):326-31. PubMed ID: 9820054
[TBL] [Abstract][Full Text] [Related]
22. [Evaluation of the antihypertensive efficacy and safety of using sustained release verapamil in elderly subjects using ambulatory blood pressure monitoring].
Jasiński T; Janicki K; Klima M; Pieniazek W; Bednarz S
Przegl Lek; 1996; 53(2):73-7. PubMed ID: 8754325
[TBL] [Abstract][Full Text] [Related]
23. The efficacy of a slow-release formulation of verapamil.
Taylor SH
Br J Clin Pract Suppl; 1985 Jun; 42():34. PubMed ID: 3929826
[No Abstract] [Full Text] [Related]
24. Study on antihypertensive efficacy of slow-release verapamil: pharmacokinetic and noninvasive hemodynamic profile.
Vulpis V; Seccia TM; Ricci S; Nazzaro P; Pirrelli A
Cardiovasc Drugs Ther; 1993 Dec; 7(6):899-900. PubMed ID: 8011568
[No Abstract] [Full Text] [Related]
25. Casual versus 24-hour ambulatory blood pressure recording in the evaluation of chronic administration of sustained-release verapamil.
Cardillo C; Savi L; Musumeci V; Mores N; Mettimano M; Costalunga A; Guerrera G; Melina D; Folli G
J Hum Hypertens; 1988 Mar; 1(4):281-5. PubMed ID: 3221375
[TBL] [Abstract][Full Text] [Related]
26. Efficacy of sustained-release verapamil: automatic ambulatory blood pressure monitoring.
Zachariah PK; Sheps SG; Schriger A
J Clin Hypertens; 1986 Sep; 2(3 Suppl):133S-142S. PubMed ID: 3540223
[TBL] [Abstract][Full Text] [Related]
27. Comparison of sustained release verapamil and hydrochlorothiazide in hypertension--effect on blood pressure and metabolic variables.
Lehtonen A; Gordin A; Salo H
Int J Clin Pharmacol Ther Toxicol; 1987 Jun; 25(6):301-5. PubMed ID: 3623734
[TBL] [Abstract][Full Text] [Related]
28. Long-term treatment of arterial hypertension with verapamil.
Wigler I; Peer G; Soferman G; Blum M; Aviram A
Int J Clin Pharmacol Ther Toxicol; 1984 Mar; 22(3):162-6. PubMed ID: 6715085
[TBL] [Abstract][Full Text] [Related]
29. Efficacy and safety of verapamil SR 240 mg in essential hypertension: results of a multicentric phase IV study.
Speders S; Sosna J; Schumacher A; Pfennigsdorf G
J Cardiovasc Pharmacol; 1989; 13 Suppl 4():S47-9. PubMed ID: 2475686
[TBL] [Abstract][Full Text] [Related]
30. [Verapamil-associated liver injury].
Odeh M; Oliven A
Harefuah; 1998 Jan; 134(1):36-7. PubMed ID: 9517278
[TBL] [Abstract][Full Text] [Related]
31. [Effects of a calcium antagonist, verapamil, on mild-moderate essential arterial hypertension].
Hergueta García de Guadiana G; Paumard Fraguas A
An Med Interna; 1989 Jan; 6(1):15-8. PubMed ID: 2491026
[TBL] [Abstract][Full Text] [Related]
32. Assessment of the Vital Signs Quality of Life Questionnaire in three studies on hypertension.
Kong BW; Bean JA; Stephens D
J Hum Hypertens; 1995 Apr; 9(4):255-62. PubMed ID: 7595908
[TBL] [Abstract][Full Text] [Related]
33. Treatment of isolated systolic hypertension in the elderly with verapamil slow-release 240 mg.
Böhmer F; Barousch R; Reinfrank J
J Cardiovasc Pharmacol; 1989; 13 Suppl 4():S45-6. PubMed ID: 2475685
[No Abstract] [Full Text] [Related]
34. Blood pressure control and cardiovascular outcomes in high-risk Hispanic patients--findings from the International Verapamil SR/Trandolapril Study (INVEST).
Cooper-DeHoff RM; Aranda JM; Gaxiola E; Cangiano JL; Garcia-Barreto D; Conti CR; Hewkin A; Pepine CJ;
Am Heart J; 2006 May; 151(5):1072-9. PubMed ID: 16644338
[TBL] [Abstract][Full Text] [Related]
35. [Slow-release verapamil 240 mg and treatment of mild to moderate hypertension].
Amabile G; Hulin P; Wajman A; Serradimigni A; Bory M
Therapie; 1989; 44(4):275-8. PubMed ID: 2595646
[TBL] [Abstract][Full Text] [Related]
36. Relationships between verapamil plasma concentrations and its antihypertensive action.
Gonzalez-Gomez A; Cires Pujols M; Gamio Capestany F; Rodriguez de la Vega A; Garcia-Barreto D
Int J Clin Pharmacol Ther Toxicol; 1988 Sep; 26(9):453-60. PubMed ID: 3198301
[TBL] [Abstract][Full Text] [Related]
37. Cardiovascular responses to verapamil and propranolol in hypertensive patients.
McInnes GT; Findlay IN; Murray G; Cleland JG; Dargie HJ
J Hypertens Suppl; 1985 Dec; 3(3):S219-21. PubMed ID: 2856708
[TBL] [Abstract][Full Text] [Related]
38. [The effect of verapamil on cardio- and hemodynamics in rats with various models of hypertension].
Spasov AA; Gurbanov KG; Seredintseva NV; Paperno AA
Eksp Klin Farmakol; 1997; 60(3):30-3. PubMed ID: 9324394
[TBL] [Abstract][Full Text] [Related]
39. [Changes in the functional level of baroreceptors under the action of verapamil in arterial hypertension].
Luna RL; Arslanian L; de Souza EM; de Oliveira PS
Arq Bras Cardiol; 1988 Oct; 51(4):297-303. PubMed ID: 3251456
[No Abstract] [Full Text] [Related]
40. [The toxicity of slow-release verapamil and chronic kidney disease].
Huelmos A; Alegría E; Vázquez C
Rev Esp Cardiol; 1994 Nov; 47(11):780. PubMed ID: 7800911
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
